Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer
Author:
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (38) , 5454-5461
Abstract
AIM: To perform a comprehensive investigation into the potential correlation between circulating myeloid-derived suppressor cells (MDSCs) and Th17 cells in esophageal cancer (ECA).Keywords
This publication has 20 references indexed in Scilit:
- Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune DiseaseThe Journal of Immunology, 2012
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayJournal of Experimental Medicine, 2009
- IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer PatientsThe Journal of Immunology, 2009
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory PathwayGastroenterology, 2008
- Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell CarcinomaClinical Cancer Research, 2007
- Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancerBritish Journal of Cancer, 2006
- Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in CancerThe Journal of Immunology, 2001